RNA regulation in neurologic disease and cancer.

The paraneoplastic neurologic diseases (PNDs) are brain degenerations that develop in the setting of clinically inapparent cancers. PNDs arise when common cancers express brain proteins, triggering an anti-tumor immune response and tumor immunity. Research on these brain-cancer proteins has revealed a new world of neuron-specific RNA binding proteins whose functions may be aberrantly used by tumor cells. Efforts to gain insight into their function has led to the development of new methods and strategies to understand RNA protein regulation in living tissues.

[1]  Robert B Darnell,et al.  β-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein , 1995, Cell.

[2]  R. Darnell.  Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Sanders,et al.  Ptosis and supranuclear downgaze paralysis , 1989, Neurology.

[4]  R. Darnell,et al.  Sequence-Specific RNA Binding by a Nova KH Domain Implications for Paraneoplastic Disease and the Fragile X Syndrome , 2000, Cell.

[5]  J. Szostak,et al.  20 In Vitro Selection of Functional RNA Sequences , 1993 .

[6]  S K Burley,et al.  The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Darnell,et al.  A T cell receptor associated with naturally occurring human tumor immunity , 2007, Proceedings of the National Academy of Sciences.

[8]  R. Darnell,et al.  Paraneoplastic syndromes affecting the nervous system. , 2006, Seminars in oncology.

[9]  R. Darnell,et al.  Developing global insight into RNA regulation. , 2006, Cold Spring Harbor symposia on quantitative biology.

[10]  Gene W. Yeo,et al.  Comprehensive discovery of endogenous Argonaute binding sites in Caenorhabditis elegans , 2010, Nature Structural &Molecular Biology.

[11]  R. Darnell,et al.  Neuroimmunology of the paraneoplastic neurological degenerations. , 2004, Current opinion in immunology.

[12]  Gene W. Yeo,et al.  Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. , 2009, Molecular cell.

[13]  H. Lou,et al.  Diverse molecular functions of Hu proteins , 2008, Cellular and Molecular Life Sciences.

[14]  R. Darnell,et al.  Nova Regulates GABAA Receptor γ2 Alternative Splicing via a Distal Downstream UCAU-Rich Intronic Splicing Enhancer , 2003, Molecular and Cellular Biology.

[15]  Loise M. Francisco,et al.  Tumor-specific killer cells in paraneoplastic cerebellar degeneration , 1998, Nature Medicine.

[16]  Scott B. Dewell,et al.  Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP , 2010, Cell.

[17]  R. Darnell,et al.  The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo , 1997, Molecular and cellular biology.

[18]  Jernej Ule,et al.  CLIP Identifies Nova-Regulated RNA Networks in the Brain , 2003, Science.

[19]  J. Henson,et al.  HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and sex-lethal , 1991, Cell.

[20]  J. Ule,et al.  iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution , 2010, Nature Structural &Molecular Biology.

[21]  Matthew Mort,et al.  Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts. , 2009, Genome research.

[22]  Donny D. Licatalosi,et al.  RNA processing and its regulation: global insights into biological networks , 2010, Nature Reviews Genetics.

[23]  Donny D. Licatalosi,et al.  Splicing Regulation in Neurologic Disease , 2006, Neuron.

[24]  D. Licatalosi,et al.  Integrative Modeling Defines the Nova Splicing-Regulatory Network and Its Combinatorial Controls , 2010, Science.

[25]  Robert B Darnell,et al.  Nova autoregulation reveals dual functions in neuronal splicing , 2005, The EMBO journal.

[26]  Tyson A. Clark,et al.  Nova regulates brain-specific splicing to shape the synapse , 2005, Nature Genetics.

[27]  R. Darnell,et al.  Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system , 1993, Neuron.

[28]  J. Posner,et al.  Antiserum from a patient with cerebellar degeneration identifies a novel protein in Purkinje cells, cortical neurons, and neuroectodermal tumors , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  R. Darnell,et al.  Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration. , 2001, Annual review of neuroscience.

[30]  Robert B Darnell,et al.  HITS‐CLIP: panoramic views of protein–RNA regulation in living cells , 2010, Wiley interdisciplinary reviews. RNA.

[31]  N. Hecht,et al.  MIWI-independent small RNAs (MSY-RNAs) bind to the RNA-binding protein, MSY2, in male germ cells , 2009, Proceedings of the National Academy of Sciences.

[32]  Tyson A. Clark,et al.  HITS-CLIP yields genome-wide insights into brain alternative RNA processing , 2008, Nature.

[33]  Andrew D. Ellington,et al.  genetic analysis: Selection and amplification of rare functional nucleic acids , 1991 .

[34]  Gene W. Yeo,et al.  An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells , 2009, Nature Structural &Molecular Biology.

[35]  RJ Buckanovich,et al.  The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  C. Cordon-Cardo,et al.  Neuronal antinuclear antibody in sensory neuronopathy from lung cancer , 1985, Neurology.

[37]  B. Blencowe,et al.  An RNA map predicting Nova-dependent splicing regulation , 2006, Nature.

[38]  R. Darnell,et al.  The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Matthew L. Albert,et al.  Paraneoplastic neurological degenerations: keys to tumour immunity , 2004, Nature Reviews Cancer.

[40]  Alexandros D. Polydorides,et al.  The splice of life: Alternative splicing and neurological disease , 2001, Nature Reviews Neuroscience.

[41]  A. Mele,et al.  Ago HITS-CLIP decodes miRNA-mRNA interaction maps , 2009, Nature.

[42]  R. Darnell,et al.  Harnessing Naturally Occurring Tumor Immunity: A Clinical Vaccine Trial in Prostate Cancer , 2010, PloS one.

[43]  R. Darnell,et al.  Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration , 2000, Annals of neurology.